Cargando…
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome
BACKGROUND: The drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome represents a severe hypersensitivity reaction. Up-to-date treatment is based on withdrawal of medication, supportive care, and immunosuppression using high-dose corticosteroid (CS) therapy. However, evidence-based...
Autores principales: | Rubin, Limor, Talmon, Aviv, Ribak, Yaarit, Kessler, Asa, Martin, Yossi, Haran, Tal Keidar, Shamriz, Oded, Adini, Irit, Tal, Yuval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175640/ https://www.ncbi.nlm.nih.gov/pubmed/37187735 http://dx.doi.org/10.3389/fimmu.2023.1134178 |
Ejemplares similares
-
Dupilumab for cancer-associated refractory pruritus
por: Talmon, Aviv, et al.
Publicado: (2023) -
Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds
por: Ribak, Yaarit, et al.
Publicado: (2023) -
Editorial: Rare immune-mediated diseases- novel insights into underlying mechanisms and therapeutic approaches
por: Shamriz, Oded, et al.
Publicado: (2023) -
Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies
por: Shamriz, Oded, et al.
Publicado: (2020) -
Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome
por: Shamriz, Oded, et al.
Publicado: (2018)